The prenatal period is a critical window for the development of autism spectrum disorder (ASD). The relationship between prenatal nutrients and gestational gene expression in mothers of children later diagnosed with ASD or nonâtypical development (NonâTD) is poorly understood. Maternal blood collected prospectively during pregnancy provides insights into the effects of nutrition, particularly oneâcarbon metabolites, on gene pathways and neurodevelopment. Genomeâwide transcriptomes were measured with microarrays in 300 maternal blood samples in Markers of Autism Risk in BabiesâLearning Early Signs. Sixteen different oneâcarbon metabolites, including folic acid, betaine, 5âČâmethyltretrahydrofolate (5âMeTHF), and dimethylglycine (DMG) were measured. Differential expression analysis and weighted gene correlation network analysis (WGCNA) were used to compare gene expression between children later diagnosed as typical development (TD), NonâTD and ASD, and to oneâcarbon metabolites. Using differential gene expression analysis, six transcripts (TGRâAS1, SQSTM1, HLAâC, and RFESD) were associated with child outcomes (ASD, NonâTD, and TD) with genomeâwide significance. Genes nominally differentially expressed between ASD and TD significantly overlapped with seven high confidence ASD genes. WGCNA identified coâexpressed gene modules significantly correlated with 5âMeTHF, folic acid, DMG, and betaine. A module enriched in DNA methylation functions showed a suggestive protective association with folic acid/5âMeTHF concentrations and ASD risk. Maternal plasma betaine and DMG concentrations were associated with a block of coâexpressed genes enriched for adaptive immune, histone modification, and RNA processing functions. These results suggest that the prenatal maternal blood transcriptome is a sensitive indicator of gestational oneâcarbon metabolite status and changes relevant to children's later neurodevelopmental outcomes.
Lay Summary
Pregnancy is a time when maternal nutrition could interact with genetic risk for autism spectrum disorder. Blood samples collected during pregnancy from mothers who had a prior child with autism were examined for gene expression and nutrient metabolites, then compared to the diagnosis of the child at age three. Expression differences in gene pathways related to the immune system and gene regulation were observed for pregnancies of children with autism and nonâtypical neurodevelopment and were associated with maternal nutrients.